Mechanisms and therapeutic strategies for overcoming MNA-mediated immune suppression in ovarian cancer

Ended Project Grant Awarded Last action

Award ID
W81XWH2210600
Recipient
Awarding agency
Obligated
$990,000

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Funding
  • $495,000.00 Federal
  • $495,000.00 Non-federal
Place of performance
2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The Department of the Army Medical Command awarded a $990,000 project grant to the Provincial Health Services Authority in Canada to support research on mechanisms and therapeutic strategies for overcoming MNA-mediated immune suppression in ovarian cancer. The grant was awarded under the Military Medical Research and Development program (CFDA 12.420), which aims to transform health care for service members and the public through innovative biomedical research solutions for battlefield medicine.

The three-year grant will fund research at BC Cancer, a part of the Provincial Health Services Authority, to investigate medical solutions for overcoming myeloid-derived suppressor cell-mediated immune suppression in ovarian cancer. The research is expected to develop novel therapeutic strategies that could transform treatment for ovarian cancer patients and support the military's goal of investigating medical solutions for the battlefield.

Quick answers

Who received award W81XWH2210600?

W81XWH2210600 was awarded to Provincial Health Services Authority by Medical Command (Department of the Army) on June 15, 2022.

How much is award W81XWH2210600 worth?

$990,000 has been obligated on W81XWH2210600: $495,000 in federal funding and $495,000 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login